Showing results (41-50 of 50) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 50 results.
Angewandte Chemie (International Ed. in English)|May 6, 2025
Evoking Simultaneous Ferroptosis and Apoptosis by a Dual-Locked Platinum (IV) Prodrug for Synergistic Chemo-immunotherapyHe Meng, Jinhui Wang, Hongyu Wen, et al.
The Journal of Physical Chemistry. A|June 1, 2022
Inference of a "Hot Ice" Layer in Nitrogen-Rich Planets: Demixing the Phase Diagram and Phase Composition for Variable Concentration Helium-Nitrogen Mixtures Based on Isothermal CompressionXiangdong Li, Hao Su, Wentao Liang, et al.
Cancer Immunology Research|March 5, 2020
Intratumoral Delivery of a PD-1-Blocking scFv Encoded in Oncolytic HSV-1 Promotes Antitumor Immunity and Synergizes with TIGIT BlockadeChaolong Lin, Wenfeng Ren, Yong Luo, et al.
Antiviral Research|March 28, 2022
A potent neutralizing and protective antibody against a conserved continuous epitope on HSV glycoprotein DRui Tian, Fei Ju, Mengqin Yu, et al.
Cancer Research|March 24, 2025
SLC3A2-Mediated Lysine Uptake by Cancer Cells Restricts T cell Activity in Hepatocellular CarcinomaYating Chang, Naizhen Wang, Shaopeng Li, et al.
Journal for Immunotherapy of Cancer|January 8, 2025
Disruption of tumor-intrinsic PGAM5 increases anti-PD-1 efficacy through the CCL2 signaling pathwayXiaoying Wei, Hong Wang, Huiquan Liu, et al.
Nature Communications|January 3, 2024
Pharmaceutical targeting of OTUB2 sensitizes tumors to cytotoxic T cells via degradation of PD-L1Wenfeng Ren, Zilong Xu, Yating Chang, et al.
Nature Communications|March 1, 2026
Targeting leucine-rich repeat kinase 2 overcomes resistance to oncolytic herpes simplex virus-based therapies in glioblastomaYaning Qin, Zhiqi Liang, Mengqin Yu, et al.
Plant Biotechnology Journal|November 26, 2025
Haplotype-Resolved Genome Assembly and Population Genomics Reveal Evolutionary History and Agronomic Traits of MulberryZhifeng Wang, Peigang Liu, Chengzhi Jiao, et al.
Journal for Immunotherapy of Cancer|June 10, 2022
Oncolytic virus expressing PD-1 inhibitors activates a collaborative intratumoral immune response to control tumor and synergizes with CTLA-4 or TIM-3 blockadeFei Ju, Yong Luo, Chaolong Lin, et al.
Pageof 5